Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma L Culver

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|February 7, 2022
A novel serum metabolomic panel distinguishes IgG4-related sclerosing cholangitis from primary sclerosing cholangitisDaniel E Radford-Smith, Emmanuel A Selvaraj, Rory Peters, et al.
Endoscopic Ultrasound|January 2, 2023
Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis - A review of cholangiographic and ultrasound imagingKathleen Möller, Barbara Braden, Emma L Culver, et al.
Rheumatology and Therapy|March 17, 2026
Efficacy and Safety of Obexelimab to Treat IgG4-Related Disease: Protocol for a Global, Randomized, Placebo-Controlled TrialEmma L Culver, Matthew C Baker, Emanuel Della-Torre, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 26, 2020
Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitisEmma L Culver, Helen K Bungay, Margaret Betts, et al.
Rheumatology and Therapy|October 4, 2023
Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled TrialCory Perugino, Emma L Culver, Arezou Khosroshahi, et al.
Journal of Gastroenterology and Hepatology|October 23, 2018
Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitisEmma L Culver, Fleur S van de Bovenkamp, Ninotska I L Derksen, et al.
Heart (British Cardiac Society)|November 8, 2024
Exploring cardiovascular involvement in IgG4-related disease: a case series approach with cardiovascular magnetic resonanceJohn Aaron Henry, Roshan Xavier, Emmanuel Selvaraj, et al.
Hepatology Communications|January 11, 2024
Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysisAyesha Shah, Michael P Jones, Gavin Callaghan, et al.
Hepatology (Baltimore, Md.)|December 5, 2025
Pruritus is common in primary sclerosing cholangitis, persists over time, and its intensity is associated with disease severityNasir Hussain, Rodrigo V Motta, Usha Gungabissoon, et al.
Plos One|October 30, 2023
Leveraging a smartphone to perform time-gated luminescence measurementsBrian E Fratto, Emma L Culver, Gabriel Davis, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Liver International : Official Journal of the International Association for the Study of the Liver|February 7, 2022
A novel serum metabolomic panel distinguishes IgG4-related sclerosing cholangitis from primary sclerosing cholangitisDaniel E Radford-Smith, Emmanuel A Selvaraj, Rory Peters, et al.
Endoscopic Ultrasound|January 2, 2023
Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis - A review of cholangiographic and ultrasound imagingKathleen Möller, Barbara Braden, Emma L Culver, et al.
Rheumatology and Therapy|March 17, 2026
Efficacy and Safety of Obexelimab to Treat IgG4-Related Disease: Protocol for a Global, Randomized, Placebo-Controlled TrialEmma L Culver, Matthew C Baker, Emanuel Della-Torre, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 26, 2020
Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitisEmma L Culver, Helen K Bungay, Margaret Betts, et al.
Rheumatology and Therapy|October 4, 2023
Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled TrialCory Perugino, Emma L Culver, Arezou Khosroshahi, et al.
Journal of Gastroenterology and Hepatology|October 23, 2018
Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitisEmma L Culver, Fleur S van de Bovenkamp, Ninotska I L Derksen, et al.
Heart (British Cardiac Society)|November 8, 2024
Exploring cardiovascular involvement in IgG4-related disease: a case series approach with cardiovascular magnetic resonanceJohn Aaron Henry, Roshan Xavier, Emmanuel Selvaraj, et al.
Hepatology Communications|January 11, 2024
Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysisAyesha Shah, Michael P Jones, Gavin Callaghan, et al.
Hepatology (Baltimore, Md.)|December 5, 2025
Pruritus is common in primary sclerosing cholangitis, persists over time, and its intensity is associated with disease severityNasir Hussain, Rodrigo V Motta, Usha Gungabissoon, et al.
Plos One|October 30, 2023
Leveraging a smartphone to perform time-gated luminescence measurementsBrian E Fratto, Emma L Culver, Gabriel Davis, et al.
Pageof 6